The ‘Global In-Vitro Diagnostics Market Trends, Report and Forecast 2023-2028’ by Expert Market Research gives an extensive outlook of the global in-vitro diagnostics market, assessing the market on the basis of its segments like product and service, technology, application, end use, and major regions.
The report studies the latest updates in the market, along with their impact across the market. It also analysis the market demand, together with its price and demand indicators. The report also tracks the market on the bases of SWOT and Porter’s Five Forces Models.
In-Vitro Diagnostics Market Size, Share, Price Trends, Industry Report, Key Players, Major Segments, and Forecast
The key highlights of the report include:
Market Overview (2018-2028)
- Forecast CAGR (2023-2028): 4.5%
|Market Size in 2022||USD 68.8 billion|
|Revenue Forecast in 2028||USD 89.55 billion|
|Growth Rate CAGR||4.5%|
|Major Players||Danaher Corp, bioMérieux, Inc, Siemens Healthcare GmbH, ARKRAY America, Inc.,|
Sysmex Corporation, F. Hoffmann-La Roche Ltd and among others.
The global in-vitro diagnostics market is expected to register growth during the forecast period on account of the increasing prevalence of diseases and infections. The advancements in automated IVD systems for hospitals and laboratories to offer accurate, error-free, and efficient diagnoses is likely to propel the market growth of in-vitro diagnostics.
Get a Free Sample Report with Table of Contents: https://www.expertmarketresearch.com/reports/in-vitro-diagnostics-market/requestsample
Due to the surge in the availability of various in-vitro diagnostics technologies introduced by various major players, the in-vitro diagnostics market growth is expected to bolster across the globe. New in-vitro diagnostics products such as molecular diagnostics offer accurate and effective results, increasing the demand for the overall market.
The rise in research and development activities being undertaken by various market competitors for the expansion of novel components is expected to drive the in-vitro diagnostics market growth. The increasing usage of in-vitro diagnostics for point-of-care testing helps healthcare providers execute testing in nursing homes, outpatient clinics, care centres, as well as patients’ homes, further enhancing the market demand for in-vitro diagnostics.
In-Vitro Diagnostics Industry Definition and Major Segments
In vitro diagnostics or IVD are refers to experiments or tests performed on samples like tissue or blood that have been extracted from a human body. IVD can identify diseases as well as other disorders and can be employed to monitor an individual’s health to help treat, prevent, or cure diseases.
Read Full Report with Table of Contents: https://www.expertmarketresearch.com/reports/in-vitro-diagnostics-market
Based on product and service, the market is classified into:
- Reagents and Kits
- Software and Services
By technology, the market is segmented into:
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Enzyme-Linked Immunospot (ELISPOT)
- Rapid Tests
- Radioimmunoassay (RIA)
- Western Blotting
- Clinical Chemistry
- Basic Metabolic Panels
- Liver Panels
- Renal Profiles
- Lipid Profiles
- Thyroid Function Panels
- Electrolyte Panels
- Specialty Chemical Tests
- Molecular Diagnostics
- Polymerize Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- DNA diagnostics
- Coagulation and Haemostasis
Based on application, the market is classified into:
- Infectious Diseases
- Drug Testing/Pharmacogenomics
- Autoimmune Diseases
By end use, the market is categorised into:
- Hospital and Clinics
- Diagnostic Laboratories
- Point-Of-Care Testing
- Academic Institutes
Based on region, the market is divided into:
- North America
- Latin America
- Asia Pacific
- Middle East and Africa
In-Vitro Diagnostics Market Trends
The infectious disease segment is likely to fuel the market growth over the coming years on account of the surging prevalence of infectious diseases. This is because in-vitro diagnostics helps to recognise microorganisms that trigger infectious diseases. Testing for life-threatening infections such as tuberculosis, HIV/AIDS, pneumonia, and hepatitis are also expected to enhance the market demand for in-vitro diagnostics.
Geographically, the North America region is anticipated to drive the in-vitro diagnostics market growth on account of the presence of major market players in the region like Danaher Corp. The well-established healthcare infrastructure in the region along with the increasing adoption of technologically advanced techniques for diagnosis are expected to drive the market growth of in-vitro diagnostics over the upcoming years.
The growing need for genetic testing for personalised medicine for conditions such as cancer and diabetes is expected to bolster the market demand for in-vitro diagnostics across North America. Increased awareness among patients about in-vitro diagnostics coupled with the rise in healthcare expenditure is likely to enhance the market growth.
Meanwhile, the Asia Pacific region is expected to gain momentum in the in-vitro diagnostics market share over the coming years on account of developments in healthcare infrastructure and testing facilities, especially in emerging economies like India and China. Rising disposable income, growing population, and wide prevalence of chronic diseases that need IVD testing are expected to boost the market growth in the region.
Key Market Players
The major players in the global in-vitro diagnostics market report are Danaher Corp, bioMérieux, Inc., Siemens Healthcare GmbH, ARKRAY America, Inc., Sysmex Corporation, and F. Hoffmann-La Roche Ltd, among others. The report covers the market shares, capacities, plant turnarounds, expansions, investments, and mergers and acquisitions, among other latest developments of these market players.
Read More Reports:
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skillful analysis and interpretation of data, the company offers its clients extensive, latest, and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.
Company Name: Claight Corporation
Contact Person: Ian Bell, Corporate Sales Specialist – U.S.A.
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA